We also summarized all cases of anti-GBM disease combined with mesangial IgA deposition published in Pubmed (http://www.ncbi.nlm.nih.gov/pubmed) to date (including our cohort, a total of 61 cases, since 1998), as shown in Table 5 (4–26). This evidence concerns the gene CD79A and glioblastoma.